Curannova Pharmaceuticcals LLC.

Who We are?

Curannova was founded in 2019 with a mission of making an exceptional difference in our patients’ lives by enabling people to lead a healthy, good quality life.

We pay extra attention to details to fill the gaps between the patients and their cure.

At Curannova, we identify, develop, and commercializing meaningful products that address unmet medical needs in the Egyptian pharmaceutical industry.

Our Vision

We are continually consolidating our position as one of the leading generic pharmaceutical companies worldwide, and we are achieving this on our own by strengthening the long-term business connections and by establishing partnerships in the fields of development, product supply and marketing.

All of this so we can deliver the best healthcare possible to every patient in need.

It’s a working process yet a vivid vision coming to life with each passing day and every treated patient.

Our Culture

At Curannova Pharmaceuticals, we believe that exceptional care comes within exceptional people with diverse pharmaceutical, chemical, and biotechnology backgrounds and customer service orientation who are devoting their efforts, eagerness, and conscience to identify our mission, vision, and core values.

With these outstanding high-performance teams, we shall continue to fulfill our mission of expanding our production of high-quality products to satisfy the needs of our community.

Our Values

Product Quality: We work on the quality of our products to ensure their efficacy and safety are up to the highest standards.
Integrity: We believe that doing our jobs with integrity and conscientiousness is the sole key to great achievements.
Teamwork: We build high-performance teams working harmoniously together to achieve assigned missions with the best possible results.
Transparency: It is an integral part of our culture as we collaborate and work towards a common goal across functions.

And on top of everything, we genuinely care for patients everywhere.

Milestones on our Journey

Our timeline

Proudly expanding our global presence across the Middle-East through impactful partnerships

Our global presence

Latest Blog Posts

Stay updated with our latest news and insights

Nov 12, 2025 36 min read

Recent advances in osteoarthritis research

Osteoarthritis (OA) is a chronic joint condition affecting millions worldwide, characterized by the gradual degeneration of joint cartilage, leading to pain, stiffness, and functional impairment. Although the pathogenesis of OA is not fully understood, the roles of inflammation, metabolic dysregulation, and biomechanical stress are increasingly recognized.

Therapeutic applications of alpha-lipoic acid: A review of clinical and preclinical evidence

Alpha-lipoic acid (ALA) is an endogenously synthesized compound known for its potent antioxidant and antiinflammatory properties, with growing interest for its therapeutic potential in conditions linked to oxidative stress. This review aims to critically evaluate the current scientific evidence on the therapeutic use of ALA, focusing on the injectable route.

Sustainable Practices in Pharmaceutical Manufacturing

With the treatment of many diseases depending on effective pharmaceuticals, the pollution caused by pharmaceuticals has become an emerging and concerning environmental problem.1 This article will tackle some sustainable practices that can be used in pharmaceutical manufacturing for improved health and environmental benefits.

Genuinely care for patients everywhere

Paying extra attention to details